TP53 and marginal zone lymphoma: The clinical significance of the site-specific subclonal TP53 alterations, confirmed by ddPCR, which we identified at low allelic frequencies (<1%) as distinct variants in lymph nodes (c.902del frameshift) and BM (c.742C>T missense), remains to be established in MZL.